Gladys Sepúlveda

415 citations
12 papers · 341 indexed · h-index 10
Topics
HIV Research and Treatment (8 papers)HIV/AIDS drug development and treatment (7 papers)HIV/AIDS Research and Interventions (5 papers)

In The Last Decade

Gladys Sepúlveda

11 papers receiving 318 citations

Peers

Gladys Sepúlveda
Comparison fields: 5 of 59
  • Infectious Diseases 254
  • Virology 214
  • Emergency Medicine 58
  • Epidemiology 40
  • Physiology 34
Replace Daniel Hirsch with:
Daniel Hirsch United States
Alessandra Cenci Italy
Valerio Tozzi Italy
Sergio Lupo Argentina
Claudia R. Avalos United States
Gilles Force France
Lara Hosey United States
Olivia Briceño Mexico
Luís A. B. Cruz Brazil
Joel Singer Canada
Gladys Sepúlveda relative to Daniel Hirsch United States Daniel Hirsch's profile →
Citations per field
00.5×3.5×
Daniel Hirsch · 1×
Citations per year

Countries citing papers authored by Gladys Sepúlveda

Since Specialization
Citations

This map shows the geographic impact of Gladys Sepúlveda's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gladys Sepúlveda with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gladys Sepúlveda more than expected).

Fields of papers citing papers by Gladys Sepúlveda

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gladys Sepúlveda. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gladys Sepúlveda. The network helps show where Gladys Sepúlveda may publish in the future.

Co-authorship network of co-authors of Gladys Sepúlveda

This figure shows the co-authorship network connecting the top 25 collaborators of Gladys Sepúlveda. A scholar is included among the top collaborators of Gladys Sepúlveda based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gladys Sepúlveda. Gladys Sepúlveda is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
#WorkIndexed citations
1 0
2 14
3 9
4 12
5 35
6 10
7 120
8 14
9 10
10 68
11 39
12 10

About Gladys Sepúlveda

Gladys Sepúlveda is a scholar working on Virology, Infectious Diseases and Endocrine and Autonomic Systems, having authored 12 papers that have together received 341 indexed citations. Recurring topics across this work include HIV Research and Treatment (8 papers), HIV/AIDS drug development and treatment (7 papers) and HIV/AIDS Research and Interventions (5 papers). The work is most often cited by research in Virology (214 citations), Infectious Diseases (254 citations) and Emergency Medicine (58 citations). Gladys Sepúlveda has collaborated with scholars based in United States, Puerto Rico and Chile. Frequent co-authors include Glenda Gray, Paul Wannamaker, Jeffrey P. Nadler, Judith Millard, Anil Kumar, Nicholaos Bellos, J. Pablo Huidobro‐Toro, Rakesh Kumar, Cristian O. Salas and Alain Fournier. Their work appears in journals such as Clinical Infectious Diseases, Journal of Neurochemistry and British Journal of Pharmacology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026